From Pulse 2.0 · Amit Chowdhry · · 50s
Sinopia Biosciences Gets NIH AI Drug Discovery Grant
Sinopia Biosciences secures $2.5m NIH grant to build AI metabolomics model for drug discovery.
In brief
Sinopia Biosciences secures $2.5m NIH grant to build AI metabolomics model for drug discovery. Sinopia Biosciences received a $2.5 million NIH grant to develop an AI-powered metabolomics foundation model for drug discovery. Originally reported by Pulse 2.0.
NIH Grant Award
Sinopia Biosciences received a $2.5 million Small Business Innovation Research Phase II grant from the National Institute of General Medical Sciences, part of the National Institutes of Health.
AI Metabolomics Model
The grant supports development and validation of an AI-powered model to integrate metabolomics data across experimental platforms, analytical methods, laboratories, and studies.
LEADS Platform Integration
Sinopia plans to incorporate the technology into its proprietary LEADS platform, which combines multi-omics data, high-throughput screening, and AI and machine learning.
Drug Discovery Focus
The model aims to identify consistent mechanisms, targets, and compounds by learning shared biological patterns across diverse metabolomics datasets.
The main idea
Sinopia Biosciences received a $2.5 million NIH grant to develop an AI-powered metabolomics foundation model for drug discovery.
